Merck's first cGMP Oligonucleotide Manufacturing suite
14 Mar 2024
In this video, Merck announces the opening of its company's first cGMP Oligonucleotide Manufacturing suite in St. Louis, MO, USA. This expansion broadens their oligo offerings to include cGMP quality oligos tailored for the diagnostic and clinical markets. The benefits of oligos made under these quality and manufacturing systems include controlled and validated processes, extensive materials traceability, batch-to-batch consistency, reproducible results, and bulk amounts.
Related Products
Request Quote for All Products
Custom cGMP Oligos
MerckIf you commercialize Molecular Diagnostics (MDx), create Laboratory Developed Tests (LDTs), or conduct preclinical research, then your final kit, assay, or modality must have an extraordinary level of quality to comply with strict regulatory or study standards. In the case of oligonucleotide raw materials available with custom specifications, the only option you should consider is Custom cGMP Oligos.